Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | HB-302/HB-301 |
Trade Name | |
Synonyms | HB-300|HB300|HB 300 |
Drug Descriptions |
HB-302/HB-301 is a combination of two arenaviruses engineered to express prostatic acid phosphatase (PAP) and prostate specific antigen (PSA), which potentially results in enhanced antitumor activity against PSA- and PAP- expressing prosate cancer cells (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C191720 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
HB-302/HB-301 | HB-302/HB-301 | 0 | 1 |